Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15


Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications.

Righi S, Ugolini M, Bottoni G, Puntoni M, Iacozzi M, Paparo F, Cabria M, Ceriani L, Gambaro M, Giovanella L, Piccardo A.

EJNMMI Res. 2018 Mar 1;8(1):18. doi: 10.1186/s13550-018-0373-9.


64Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.

Yoshii Y, Yoshimoto M, Matsumoto H, Furukawa T, Zhang MR, Inubushi M, Tsuji AB, Fujibayashi Y, Higashi T, Saga T.

Oncotarget. 2017 Sep 28;8(51):88815-88826. doi: 10.18632/oncotarget.21323. eCollection 2017 Oct 24.


Multiple Administrations of 64Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts.

Yoshii Y, Matsumoto H, Yoshimoto M, Zhang MR, Oe Y, Kurihara H, Narita Y, Jin ZH, Tsuji AB, Yoshinaga K, Fujibayashi Y, Higashi T.

Transl Oncol. 2018 Feb;11(1):24-30. doi: 10.1016/j.tranon.2017.10.006. Epub 2017 Nov 17.


Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Holland JP, Ferdani R, Anderson CJ, Lewis JS.

PET Clin. 2009 Jan;4(1):49-67. doi: 10.1016/j.cpet.2009.04.013.


Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission.

McMillan DD, Maeda J, Bell JJ, Genet MD, Phoonswadi G, Mann KA, Kraft SL, Kitamura H, Fujimori A, Yoshii Y, Furukawa T, Fujibayashi Y, Kato TA.

J Radiat Res. 2015 Sep;56(5):784-91. doi: 10.1093/jrr/rrv042. Epub 2015 Aug 6.


Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.

Zhou M, Chen Y, Adachi M, Wen X, Erwin B, Mawlawi O, Lai SY, Li C.

Biomaterials. 2015 Jul;57:41-9. doi: 10.1016/j.biomaterials.2015.04.013. Epub 2015 Apr 24.


Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Verwer EE, Boellaard R, van der Veldt AA.

World J Clin Oncol. 2014 Dec 10;5(5):824-44. doi: 10.5306/wjco.v5.i5.824. Review.


Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.

Yoshii Y, Matsumoto H, Yoshimoto M, Furukawa T, Morokoshi Y, Sogawa C, Zhang MR, Wakizaka H, Yoshii H, Fujibayashi Y, Saga T.

PLoS One. 2014 Jan 22;9(1):e86996. doi: 10.1371/journal.pone.0086996. eCollection 2014.


Cancer theranostics with near-infrared light-activatable multimodal nanoparticles.

Melancon MP, Zhou M, Li C.

Acc Chem Res. 2011 Oct 18;44(10):947-56. doi: 10.1021/ar200022e. Epub 2011 Aug 17. Review.


Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Bhattacharyya S, Dixit M.

Dalton Trans. 2011 Jun 21;40(23):6112-28. doi: 10.1039/c1dt10379b. Epub 2011 May 3.


A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo.

Hancock CN, Stockwin LH, Han B, Divelbiss RD, Jun JH, Malhotra SV, Hollingshead MG, Newton DL.

Free Radic Biol Med. 2011 Jan 1;50(1):110-21. doi: 10.1016/j.freeradbiomed.2010.10.696. Epub 2010 Nov 4.


Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Wadas TJ, Wong EH, Weisman GR, Anderson CJ.

Chem Rev. 2010 May 12;110(5):2858-902. doi: 10.1021/cr900325h. Review. No abstract available.


Unconventional nuclides for radiopharmaceuticals.

Holland JP, Williamson MJ, Lewis JS.

Mol Imaging. 2010 Feb;9(1):1-20. Review.


Auger processes in the 21st century.

Howell RW.

Int J Radiat Biol. 2008 Dec;84(12):959-75. doi: 10.1080/09553000802395527. Review. Erratum in: Int J Radiat Biol. 2013 Jul;89(7):593. Int J Radiat Biol. 2013 Jan;89(1):67.


Targeted molecular imaging in oncology: focus on radiation therapy.

Nimmagadda S, Ford EC, Wong JW, Pomper MG.

Semin Radiat Oncol. 2008 Apr;18(2):136-48. doi: 10.1016/j.semradonc.2007.10.009. Review.

Supplemental Content

Support Center